Salivary duct carcinoma (SDC) is a rare, aggressive malignancy with limited treatment
options and poor outcome. Twenty-nine primary resected SDC, including 15 SDC de novo …

Although the histologically diverse classification of salivary gland tumors can be successfully
applied to the epithelial lacrimal gland neoplasms, it is not clear whether the molecular …

Salivary duct carcinoma (SDC) is a rare malignancy arising from the major and minor
salivary glands. 1, 2 Though curative intent surgery followed by radiation is the treatment of …

BACKGROUND Patients with advanced primary and recurrent salivary duct carcinoma
(SDC), a rare and lethal malignancy, have limited therapeutic options. Novel small‐molecule …

Purpose: We sought to identify genomic alterations (GA) in salivary gland adenocarcinomas,
not otherwise specified (NOS), salivary duct carcinomas (SDC), carcinoma ex pleomorphic …

Salivary duct carcinoma (SDC) is a high-grade salivary gland carcinoma that is associated
with frequent metastasis and poor outcome. Androgen receptor (AR) immunoexpression in …

Salivary duct carcinoma (SDC) is an aggressive neoplasm that resembles high-grade
invasive ductal carcinoma of the breast. It can develop de novo or from the malignant …

Purpose: Previous evaluation of HER2 overexpression in salivary gland cancers indicated
an incidence varying between 7 and 56%, with no clear difference among three …

Di Palma S, Simpson RHW, Marchiò C, Skálová A, Ungari M, Sandison A, Whitaker S, Parry
S & Reis‐Filho JS (2012) Histopathology 61, 629–643 Salivary duct carcinomas can be …

Objectives PD-1/PD-L1 and CTLA-4 have been investigated and are thought to play an
important role in tumor evasion. This study aimed to investigate expression patterns of …